English

HUMAN GENOME SCIENCES INC

EDGAR

HGSI Quarterly report (10-Q) · filed 2012-07-26

77 filing records in this dataset, filed from 1996-05-13 to 2012-07-26. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

60.3 million USD

2012 Q2 · USD

Exact inputs and evidence

Revenue: 60342000 USD Source

Operating margin

-124.61%

2012 Q2 · %

Exact inputs and evidence

Operating Income: -75191000 USD Source
Revenue: 60342000 USD Source

Cash and cash equivalents: 350 million USD 2012-06-30 Source
Exact value

349958000 USD
Long-term debt including current maturities: 814 million Unit12 2011-12-31 Source
Exact value

813840000 Unit12
Shares outstanding: 199 million Unit1 2011-12-31 Source
Exact value

198750531 Unit1

Reported share-count change

5.17% · 9.77 million Unit1

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

188980748 Unit1 · 2010-12-31· Source
198750531 Unit1 · 2011-12-31· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2012-07-26.

Financial data available through: 2011-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2011-12-31
Operating income: 3 of 11 periods available· newest 2011-12-31
Net income: 3 of 11 periods available· newest 2011-12-31
Operating cash flow: 3 of 11 periods available· newest 2011-12-31
Capital expenditure: 3 of 11 periods available· newest 2011-12-31
Total assets: Multiple units; comparison withheld· newest 2011-12-31
Total liabilities: Multiple units; comparison withheld· newest 2011-12-31
Current assets: Multiple units; comparison withheld· newest 2011-12-31
Current liabilities: Multiple units; comparison withheld· newest 2011-12-31
Cash and cash equivalents: Multiple units; comparison withheld· newest 2011-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2011-12-31
Shares outstanding: 2 of 11 periods available· newest 2011-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-16.8%

Prior period

Unit12 157.35 million

2010-01-01 – 2010-12-31
Current period

Unit12 130.98 million

2011-01-01 – 2011-12-31

Exact inputs and evidence

130975000 − 157351000 = -26376000 Unit12

157351000 Unit12 · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
130975000 Unit12 · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · HUMAN GENOME SCIENCES INC · 2011-12-31 HUMAN GENOME SCIENCES INC (edgar:901219) Year-over-year change in Revenue: -26376000 Unit12 Concept: fundies:Revenue Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-03T13:03:03Z Snapshot: 39a5c6ef1a20180513f13cda73c7135e1c2d3061e77cfc6eba75aaa71cd2edf0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/901219?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 130975000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/901219/000119312512085140/hgsi-20111231.xml#1256476 Filing: 000119312512085140 Input fundies:Revenue: 157351000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/901219/000119312512085140/hgsi-20111231.xml#1255787 Filing: 000119312512085140
The citation records this snapshot. The page link may show a newer release later.
Net income
−Unit12 147.88 million

Prior period

−Unit12 233.23 million

2010-01-01 – 2010-12-31
Current period

−Unit12 381.11 million

2011-01-01 – 2011-12-31

Exact inputs and evidence

-381106000 − -233231000 = -147875000 Unit12

-233231000 Unit12 · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
-381106000 Unit12 · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · HUMAN GENOME SCIENCES INC · 2011-12-31 HUMAN GENOME SCIENCES INC (edgar:901219) Year-over-year change in Net income: -147875000 Unit12 Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-03T13:03:03Z Snapshot: 39a5c6ef1a20180513f13cda73c7135e1c2d3061e77cfc6eba75aaa71cd2edf0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/901219?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -381106000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/901219/000119312512085140/hgsi-20111231.xml#1145669 Filing: 000119312512085140 Input fundies:NetIncome: -233231000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/901219/000119312512085140/hgsi-20111231.xml#1144789 Filing: 000119312512085140
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−Unit12 117.23 million

Prior period

−Unit12 280.69 million

2010-01-01 – 2010-12-31
Current period

−Unit12 397.92 million

2011-01-01 – 2011-12-31

Exact inputs and evidence

-397919000 − -280689000 = -117230000 Unit12

-280689000 Unit12 · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
-397919000 Unit12 · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · HUMAN GENOME SCIENCES INC · 2011-12-31 HUMAN GENOME SCIENCES INC (edgar:901219) Year-over-year change in Operating cash flow: -117230000 Unit12 Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-03T13:03:03Z Snapshot: 39a5c6ef1a20180513f13cda73c7135e1c2d3061e77cfc6eba75aaa71cd2edf0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/901219?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -397919000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/901219/000119312512085140/hgsi-20111231.xml#1144126 Filing: 000119312512085140 Input fundies:OperatingCashFlow: -280689000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/901219/000119312512085140/hgsi-20111231.xml#1143932 Filing: 000119312512085140
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+94.1%

Prior period

Unit12 9.78 million

2010-01-01 – 2010-12-31
Current period

Unit12 18.99 million

2011-01-01 – 2011-12-31

Exact inputs and evidence

18989000 − 9782000 = 9207000 Unit12

9782000 Unit12 · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
18989000 Unit12 · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · HUMAN GENOME SCIENCES INC · 2011-12-31 HUMAN GENOME SCIENCES INC (edgar:901219) Year-over-year change in Capital expenditure: 9207000 Unit12 Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-03T13:03:03Z Snapshot: 39a5c6ef1a20180513f13cda73c7135e1c2d3061e77cfc6eba75aaa71cd2edf0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/901219?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 18989000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/901219/000119312512085140/hgsi-20111231.xml#1163582 Filing: 000119312512085140 Input fundies:CapitalExpenditure: 9782000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/901219/000119312512085140/hgsi-20111231.xml#1163391 Filing: 000119312512085140
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2011 2011-01-01 – 2011-12-31

Revenue Unit12 130.98 million 100% of revenue
Operating costs Derived Unit12 460.53 million 352% of revenue
Operating income −Unit12 329.55 million −252% of revenue
Tax, interest and other Derived Unit12 51.56 million 39% of revenue
Net income −Unit12 381.11 million −291% of revenue

Cash

Operating cash flow −Unit12 397.92 million −304% of revenue
Capital expenditure Unit12 18.99 million 14% of revenue
Free cash flow Derived −Unit12 416.91 million −318% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2009 98%
2010 Operating loss: operating costs were 221% of revenue.
2011 Operating loss: operating costs were 352% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2009 2009-01-01 – 2009-12-31	275749000	269561000 Derived	6188000	529000 Derived	5659000	-10351000 Derived	Source 2009-01-01 – 2009-12-31: 275749000 Unit12 Inspect Revenue Open source 2009-01-01 – 2009-12-31: 6188000 Unit12 Inspect Operating Income Open source 2009-01-01 – 2009-12-31: 5659000 Unit12 Inspect Net Income Open source 2009-01-01 – 2009-12-31: -332000 Unit12 Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 10019000 Unit12 Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	157351000	348124000 Derived	-190773000	42458000 Derived	-233231000	-290471000 Derived	Source 2010-01-01 – 2010-12-31: 157351000 Unit12 Inspect Revenue Open source 2010-01-01 – 2010-12-31: -190773000 Unit12 Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -233231000 Unit12 Inspect Net Income Open source 2010-01-01 – 2010-12-31: -280689000 Unit12 Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 9782000 Unit12 Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	130975000	460526000 Derived	-329551000	51555000 Derived	-381106000	-416908000 Derived	Source 2011-01-01 – 2011-12-31: 130975000 Unit12 Inspect Revenue Open source 2011-01-01 – 2011-12-31: -329551000 Unit12 Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -381106000 Unit12 Inspect Net Income Open source 2011-01-01 – 2011-12-31: -397919000 Unit12 Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 18989000 Unit12 Inspect Capital Expenditure Open source

Amounts are exact, in Unit12.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit12 131M 2011

Values and sources

Revenue values and source evidence
Period	Series	Value(Unit12)	Source evidence
20092009-12-31	Revenue	275749000	Revenue: 275749000 Open source
20102010-12-31	Revenue	157351000	Revenue: 157351000 Open source
20112011-12-31	Revenue	130975000	Revenue: 130975000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-16.8% 2011

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Year over year	No prior comparable period	Revenue: 275749000 Open source
20102010-12-31	Year over year	-42.9%	Revenue: 157351000 Open source Revenue: 275749000 Open source
20112011-12-31	Year over year	-16.8%	Revenue: 130975000 Open source Revenue: 157351000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -251.6% 2011

Net margin -291% 2011

Free cash flow margin -318.3% 2011

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Operating margin	2.2%	Operating Income: 6188000 Open source Revenue: 275749000 Open source
20102010-12-31	Operating margin	-121.2%	Operating Income: -190773000 Open source Revenue: 157351000 Open source
20112011-12-31	Operating margin	-251.6%	Operating Income: -329551000 Open source Revenue: 130975000 Open source
20092009-12-31	Net margin	2.1%	Net Income: 5659000 Open source Revenue: 275749000 Open source
20102010-12-31	Net margin	-148.2%	Net Income: -233231000 Open source Revenue: 157351000 Open source
20112011-12-31	Net margin	-291%	Net Income: -381106000 Open source Revenue: 130975000 Open source
20092009-12-31	Free cash flow margin	-3.8%	Revenue: 275749000 Open source Operating Cash Flow: -332000 Open source Capital Expenditure: 10019000 Open source
20102010-12-31	Free cash flow margin	-184.6%	Revenue: 157351000 Open source Operating Cash Flow: -280689000 Open source Capital Expenditure: 9782000 Open source
20112011-12-31	Free cash flow margin	-318.3%	Revenue: 130975000 Open source Operating Cash Flow: -397919000 Open source Capital Expenditure: 18989000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

Unit12 -397.9M 2011

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(Unit12)	Source evidence
20092009-12-31	Operating cash flow	-332000	Operating Cash Flow: -332000 Open source
20102010-12-31	Operating cash flow	-280689000	Operating Cash Flow: -280689000 Open source
20112011-12-31	Operating cash flow	-397919000	Operating Cash Flow: -397919000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Unit12 -416.9M 2011

Values and sources

Free cash flow values and source evidence
Period	Series	Value(Unit12)	Source evidence
20092009-12-31	Free cash flow	-10351000	Operating Cash Flow: -332000 Open source Capital Expenditure: 10019000 Open source
20102010-12-31	Free cash flow	-290471000	Operating Cash Flow: -280689000 Open source Capital Expenditure: 9782000 Open source
20112011-12-31	Free cash flow	-416908000	Operating Cash Flow: -397919000 Open source Capital Expenditure: 18989000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2009-12-31	Liabilities / assets	Not reported	No source recorded
2010-12-31	Liabilities / assets	Not reported	No source recorded
2011-12-31	Liabilities / assets	Not reported	No source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2009-12-31	Current assets / current liabilities	Not reported	No source recorded
2010-12-31	Current assets / current liabilities	Not reported	No source recorded
2011-12-31	Current assets / current liabilities	Not reported	No source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2009 2009-01-01 – 2009-12-31	Unit12 5.66 million Exact value Exact value: 5659000 Unit12 2009-01-01 – 2009-12-31: 5659000 Unit12 Inspect Net Income Open source Share or cite Citation for Net Income · HUMAN GENOME SCIENCES INC · 2009-12-31 HUMAN GENOME SCIENCES INC (edgar:901219) Net Income: 5659000 Unit12 Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-03T13:03:03Z Snapshot: 39a5c6ef1a20180513f13cda73c7135e1c2d3061e77cfc6eba75aaa71cd2edf0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/901219/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=Unit12&dimensions= Input fundies:NetIncome: 5659000 Unit12 (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/901219/000119312512085140/hgsi-20111231.xml#1144320 Filing: 000119312512085140 The citation records this snapshot. The page link may show a newer release later.	−Unit12 332,000 Exact value Exact value: -332000 Unit12 2009-01-01 – 2009-12-31: -332000 Unit12 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HUMAN GENOME SCIENCES INC · 2009-12-31 HUMAN GENOME SCIENCES INC (edgar:901219) Operating Cash Flow: -332000 Unit12 Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-03T13:03:03Z Snapshot: 39a5c6ef1a20180513f13cda73c7135e1c2d3061e77cfc6eba75aaa71cd2edf0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/901219/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=Unit12&dimensions= Input fundies:OperatingCashFlow: -332000 Unit12 (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/901219/000119312512085140/hgsi-20111231.xml#1143741 Filing: 000119312512085140 The citation records this snapshot. The page link may show a newer release later.	Unit12 10.02 million Exact value Exact value: 10019000 Unit12 2009-01-01 – 2009-12-31: 10019000 Unit12 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HUMAN GENOME SCIENCES INC · 2009-12-31 HUMAN GENOME SCIENCES INC (edgar:901219) Capital Expenditure: 10019000 Unit12 Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-03T13:03:03Z Snapshot: 39a5c6ef1a20180513f13cda73c7135e1c2d3061e77cfc6eba75aaa71cd2edf0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/901219/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=Unit12&dimensions= Input fundies:CapitalExpenditure: 10019000 Unit12 (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/901219/000119312512085140/hgsi-20111231.xml#1163199 Filing: 000119312512085140 The citation records this snapshot. The page link may show a newer release later.	−Unit12 10.35 million Calculation and evidence -332000 − 10019000 Unit12 Exact free cash flow: -10351000 Unit12 2009-01-01 – 2009-12-31: -332000 Unit12 · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 10019000 Unit12 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HUMAN GENOME SCIENCES INC · 2009-12-31 HUMAN GENOME SCIENCES INC (edgar:901219) Free cash flow: -10351000 Unit12 Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-03T13:03:03Z Snapshot: 39a5c6ef1a20180513f13cda73c7135e1c2d3061e77cfc6eba75aaa71cd2edf0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/901219?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -332000 Unit12 (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/901219/000119312512085140/hgsi-20111231.xml#1143741 Filing: 000119312512085140 Input fundies:CapitalExpenditure: 10019000 Unit12 (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/901219/000119312512085140/hgsi-20111231.xml#1163199 Filing: 000119312512085140 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−Unit12 233.23 million Exact value Exact value: -233231000 Unit12 2010-01-01 – 2010-12-31: -233231000 Unit12 Inspect Net Income Open source Share or cite Citation for Net Income · HUMAN GENOME SCIENCES INC · 2010-12-31 HUMAN GENOME SCIENCES INC (edgar:901219) Net Income: -233231000 Unit12 Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-03T13:03:03Z Snapshot: 39a5c6ef1a20180513f13cda73c7135e1c2d3061e77cfc6eba75aaa71cd2edf0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/901219/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=Unit12&dimensions= Input fundies:NetIncome: -233231000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/901219/000119312512085140/hgsi-20111231.xml#1144789 Filing: 000119312512085140 The citation records this snapshot. The page link may show a newer release later.	−Unit12 280.69 million Exact value Exact value: -280689000 Unit12 2010-01-01 – 2010-12-31: -280689000 Unit12 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HUMAN GENOME SCIENCES INC · 2010-12-31 HUMAN GENOME SCIENCES INC (edgar:901219) Operating Cash Flow: -280689000 Unit12 Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-03T13:03:03Z Snapshot: 39a5c6ef1a20180513f13cda73c7135e1c2d3061e77cfc6eba75aaa71cd2edf0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/901219/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=Unit12&dimensions= Input fundies:OperatingCashFlow: -280689000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/901219/000119312512085140/hgsi-20111231.xml#1143932 Filing: 000119312512085140 The citation records this snapshot. The page link may show a newer release later.	Unit12 9.78 million Exact value Exact value: 9782000 Unit12 2010-01-01 – 2010-12-31: 9782000 Unit12 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HUMAN GENOME SCIENCES INC · 2010-12-31 HUMAN GENOME SCIENCES INC (edgar:901219) Capital Expenditure: 9782000 Unit12 Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-03T13:03:03Z Snapshot: 39a5c6ef1a20180513f13cda73c7135e1c2d3061e77cfc6eba75aaa71cd2edf0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/901219/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=Unit12&dimensions= Input fundies:CapitalExpenditure: 9782000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/901219/000119312512085140/hgsi-20111231.xml#1163391 Filing: 000119312512085140 The citation records this snapshot. The page link may show a newer release later.	−Unit12 290.47 million Calculation and evidence -280689000 − 9782000 Unit12 Exact free cash flow: -290471000 Unit12 2010-01-01 – 2010-12-31: -280689000 Unit12 · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 9782000 Unit12 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HUMAN GENOME SCIENCES INC · 2010-12-31 HUMAN GENOME SCIENCES INC (edgar:901219) Free cash flow: -290471000 Unit12 Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-03T13:03:03Z Snapshot: 39a5c6ef1a20180513f13cda73c7135e1c2d3061e77cfc6eba75aaa71cd2edf0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/901219?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -280689000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/901219/000119312512085140/hgsi-20111231.xml#1143932 Filing: 000119312512085140 Input fundies:CapitalExpenditure: 9782000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/901219/000119312512085140/hgsi-20111231.xml#1163391 Filing: 000119312512085140 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−Unit12 381.11 million Exact value Exact value: -381106000 Unit12 2011-01-01 – 2011-12-31: -381106000 Unit12 Inspect Net Income Open source Share or cite Citation for Net Income · HUMAN GENOME SCIENCES INC · 2011-12-31 HUMAN GENOME SCIENCES INC (edgar:901219) Net Income: -381106000 Unit12 Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-03T13:03:03Z Snapshot: 39a5c6ef1a20180513f13cda73c7135e1c2d3061e77cfc6eba75aaa71cd2edf0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/901219/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=Unit12&dimensions= Input fundies:NetIncome: -381106000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/901219/000119312512085140/hgsi-20111231.xml#1145669 Filing: 000119312512085140 The citation records this snapshot. The page link may show a newer release later.	−Unit12 397.92 million Exact value Exact value: -397919000 Unit12 2011-01-01 – 2011-12-31: -397919000 Unit12 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HUMAN GENOME SCIENCES INC · 2011-12-31 HUMAN GENOME SCIENCES INC (edgar:901219) Operating Cash Flow: -397919000 Unit12 Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-03T13:03:03Z Snapshot: 39a5c6ef1a20180513f13cda73c7135e1c2d3061e77cfc6eba75aaa71cd2edf0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/901219/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=Unit12&dimensions= Input fundies:OperatingCashFlow: -397919000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/901219/000119312512085140/hgsi-20111231.xml#1144126 Filing: 000119312512085140 The citation records this snapshot. The page link may show a newer release later.	Unit12 18.99 million Exact value Exact value: 18989000 Unit12 2011-01-01 – 2011-12-31: 18989000 Unit12 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HUMAN GENOME SCIENCES INC · 2011-12-31 HUMAN GENOME SCIENCES INC (edgar:901219) Capital Expenditure: 18989000 Unit12 Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-03T13:03:03Z Snapshot: 39a5c6ef1a20180513f13cda73c7135e1c2d3061e77cfc6eba75aaa71cd2edf0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/901219/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=Unit12&dimensions= Input fundies:CapitalExpenditure: 18989000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/901219/000119312512085140/hgsi-20111231.xml#1163582 Filing: 000119312512085140 The citation records this snapshot. The page link may show a newer release later.	−Unit12 416.91 million Calculation and evidence -397919000 − 18989000 Unit12 Exact free cash flow: -416908000 Unit12 2011-01-01 – 2011-12-31: -397919000 Unit12 · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 18989000 Unit12 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HUMAN GENOME SCIENCES INC · 2011-12-31 HUMAN GENOME SCIENCES INC (edgar:901219) Free cash flow: -416908000 Unit12 Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-03T13:03:03Z Snapshot: 39a5c6ef1a20180513f13cda73c7135e1c2d3061e77cfc6eba75aaa71cd2edf0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/901219?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -397919000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/901219/000119312512085140/hgsi-20111231.xml#1144126 Filing: 000119312512085140 Input fundies:CapitalExpenditure: 18989000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/901219/000119312512085140/hgsi-20111231.xml#1163582 Filing: 000119312512085140 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

77 filings · 781 latest values · 781 originally reported values

Dataset published 2026-11-03. Source filing dates and reporting periods are shown separately.

Identifiers: 0000901219, 901219, HGSI, edgar:901219

Also known as HUMAN GENOME SCIENCES INC

HUMAN GENOME SCIENCES INC

Latest quarter

Revenue

Operating margin

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2011 2011-01-01 – 2011-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation